Cyclo Therapeutics Stock Forecast - Naive Prediction
| CYTHDelisted Stock | USD 0.72 0.06 9.09% |
Cyclo Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Cyclo Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 26th of January 2026, The value of RSI of Cyclo Therapeutics' share price is at 50 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Cyclo Therapeutics, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
Using Cyclo Therapeutics hype-based prediction, you can estimate the value of Cyclo Therapeutics from the perspective of Cyclo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Cyclo Therapeutics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.79. Cyclo Therapeutics after-hype prediction price | USD 0.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cyclo |
Cyclo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cyclo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyclo using various technical indicators. When you analyze Cyclo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cyclo Therapeutics Naive Prediction Price Forecast For the 27th of January
Given 90 days horizon, the Naive Prediction forecasted value of Cyclo Therapeutics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.79.Please note that although there have been many attempts to predict Cyclo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cyclo Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cyclo Therapeutics Stock Forecast Pattern
| Backtest Cyclo Therapeutics | Cyclo Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cyclo Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Cyclo Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.6416 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0458 |
| MAPE | Mean absolute percentage error | 0.0567 |
| SAE | Sum of the absolute errors | 2.7921 |
Predictive Modules for Cyclo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyclo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Cyclo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyclo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cyclo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cyclo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cyclo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyclo Therapeutics' historical news coverage. Cyclo Therapeutics' after-hype downside and upside margins for the prediction period are 0.72 and 0.72, respectively. We have considered Cyclo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cyclo Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Cyclo Therapeutics is based on 3 months time horizon.
Cyclo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cyclo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyclo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyclo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 12 Events / Month | 5 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.72 | 0.72 | 0.00 |
|
Cyclo Therapeutics Hype Timeline
Cyclo Therapeutics is currently traded for 0.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cyclo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Cyclo Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.72. About 48.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.9. Cyclo Therapeutics last dividend was issued on the 9th of December 2020. The entity had 1:100 split on the 9th of December 2020. Given the investment horizon of 90 days the next anticipated press release will be in about 12 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.Cyclo Therapeutics Related Hype Analysis
Having access to credible news sources related to Cyclo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cyclo Therapeutics' future price movements. Getting to know how Cyclo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyclo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IVC | Invacare | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ELUT | Elutia Inc | 0.04 | 6 per month | 4.92 | 0.03 | 9.52 | (7.27) | 32.08 | |
| RNLX | Renalytix AI | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LSB | LakeShore Biopharma Co | (0.03) | 7 per month | 8.14 | 0.01 | 12.33 | (12.50) | 91.99 | |
| ELEV | Elevation Oncology | 1.00 | 15 per month | 3.35 | 0.04 | 9.09 | (6.67) | 29.95 | |
| STRM | Streamline Health Solutions | 0.11 | 15 per month | 0.67 | 0.10 | 2.22 | (1.92) | 126.78 | |
| MSPR | MSP Recovery | (0.02) | 9 per month | 0.00 | (0.03) | 45.45 | (36.84) | 200.36 | |
| TRAW | Traws Pharma | (0.06) | 8 per month | 8.23 | 0 | 17.70 | (10.71) | 58.96 | |
| MEIP | MEIP Old | 1.00 | 11 per month | 7.01 | 0.09 | 11.67 | (11.72) | 60.63 | |
| HEXO | Hexo Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cyclo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cyclo Therapeutics stock to make a market-neutral strategy. Peer analysis of Cyclo Therapeutics could also be used in its relative valuation, which is a method of valuing Cyclo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cyclo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cyclo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyclo Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyclo Therapeutics stock market strength indicators, traders can identify Cyclo Therapeutics entry and exit signals to maximize returns.
Cyclo Therapeutics Risk Indicators
The analysis of Cyclo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cyclo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cyclo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.64 | |||
| Semi Deviation | 5.5 | |||
| Standard Deviation | 8.65 | |||
| Variance | 74.74 | |||
| Downside Variance | 40.22 | |||
| Semi Variance | 30.23 | |||
| Expected Short fall | (6.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cyclo Therapeutics
The number of cover stories for Cyclo Therapeutics depends on current market conditions and Cyclo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cyclo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cyclo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cyclo Therapeutics Short Properties
Cyclo Therapeutics' future price predictability will typically decrease when Cyclo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cyclo Therapeutics often depends not only on the future outlook of the potential Cyclo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.3 M | |
| Cash And Short Term Investments | 9.2 M | |
| Shares Float | 11.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Cyclo Stock
If you are still planning to invest in Cyclo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyclo Therapeutics' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |